STOCK TITAN

[Form 4] ICU MEDICAL INC/DE Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Vivek Jain, Chairman and CEO of ICU Medical, reported a Form 4 disclosing transactions dated 09/12/2025. The filing shows a gift of 63,641 shares of common stock to two trusts established for family members who share the same household; the reporting person disclaims beneficial ownership of the shares held by those trusts. After the reported transactions, Mr. Jain retained 66,508 shares directly and the trusts hold 152,339 shares indirectly. The form was signed by an attorney-in-fact on 09/15/2025.

Vivek Jain, presidente e amministratore delegato di ICU Medical, ha presentato un Form 4 che rivela operazioni datate 09/12/2025. La dichiarazione mostra un regalo di 63,641 azioni ordinarie a due trust istituiti per membri della famiglia che condividono lo stesso domicilio; la persona riportante nega la proprietà beneficiaria delle azioni detenute da tali trust. Dopo le operazioni riportate, il signor Jain detiene direttamente 66,508 azioni e i trust detengono indirettamente 152,339 azioni. Il modulo è stato firmato da un procuratore il 09/15/2025.

Vivek Jain, presidente y director ejecutivo de ICU Medical, presentó un Form 4 que revela transacciones fechadas el 09/12/2025. La declaración muestra un regalo de 63,641 acciones comunes a dos fideicomisos establecidos para miembros de la familia que comparten el mismo domicilio; la persona informante niega la titularidad beneficiosa de las acciones que poseen esos fideicomisos. Después de las transacciones reportadas, el Sr. Jain retiene directamente 66,508 acciones y los fideicomisos poseen indirectamente 152,339 acciones. El formulario fue firmado por un apoderado el 09/15/2025.

Vivek Jain, ICU Medical의 회장 겸 CEO가 09/12/2025로 기재된 거래를 밝히는 Form 4를 보고했습니다. 제출 문서는 같은 거주지를 공유하는 가족 구성원을 위해 설립된 두 개의 트러스트에 63,641주 자사주가 증여되었음을 보여주며, 보고자는 해당 트러스트가 보유한 주식에 대한 실질적 소유권을 부인합니다. 보고된 거래 이후 Jain 씨는 직접 66,508주를 보유하고 있으며 트러스트는 간접적으로 152,339주를 보유합니다. 양식은 09/15/2025에 대리인이 서명했습니다.

Vivek Jain, président-directeur général d'ICU Medical, a déclaré un Form 4 révélant des transactions datées du 09/12/2025. Le dépôt montre un don de 63 641 actions ordinaires à deux fiducies établies pour des membres de la famille qui partagent le même domicile; la personne déclarant nie la propriété bénéficiaire des actions détenues par ces fiducies. Après les transactions signalées, M. Jain détenait directement 66 508 actions et les fiducies détenaient indirectement 152 339 actions. Le formulaire a été signé par un mandataire le 09/15/2025.

Vivek Jain, Vorsitzender und CEO von ICU Medical, hat einen Form 4 eingereicht, der Transaktionen datiert auf den 09/12/2025 offenlegt. Die Einreichung zeigt eine Schenkung von 63.641 Stammaktien an zwei Treuhandfonds, die für Familienmitglieder eingerichtet wurden, die im selben Haushalt leben; die meldende Person bestreitet das wirtschaftliche Eigentum an den Aktien, die von diesen Treuhandfonds gehalten werden. Nach den gemeldeten Transaktionen hielt Herr Jain direkt 66.508 Aktien, und die Treuhandfonds hielten indirekt 152.339 Aktien. Das Formular wurde von einem Bevollmächtigten am 09/15/2025 unterschrieben.

Vivek Jain، رئيس مجلس الإدارة والمدير التنفيذي لـ ICU Medical، أبلغ عن نموذج Form 4 يكشف عن معاملات بتاريخ 09/12/2025. يظهر الإيداع هدية من 63,641 سهماً عادياً إلى اثنين من الصناديق الوصيّة (trusts) المعبأة لأعضاء العائلة الذين يعيشون في نفس المنزل؛ المستلم يَنفي الملكية المفيدة للأسهم التي تملكها تلك الصناديق. بعد المعاملات المبلغ عنها، يحتفظ السيد جان مباشرة بـ 66,508 سهماً، وتملك الصناديق 152,339 سهماً بشكل غير مباشر. وتم توقيع النموذج من قبل وكيل في الـ 09/15/2025.

Vivek Jain,ICU Medical 的董事长兼首席执行官,披露了截至 09/12/2025 的 Form 4 交易。文件显示向为同一家庭成员设立的两只信托基金转让 63,641 股普通股;报告人否认对这些信托所持股票的受益所有权。交易披露后,Jain先生直接持有 66,508 股,信托间接持有 152,339 股。该表格由代理人于 09/15/2025 签署。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider gift of 63,641 shares by the CEO is a non-sale transfer for estate or family planning, producing no immediate cash impact.

The Form 4 documents a non-sale transaction: 63,641 shares were transferred as a gift to two family trusts, with the reporting person disclaiming beneficial ownership of those trust-held shares. Direct holdings remain 66,508 shares while indirect trust holdings total 152,339 shares. This is a disclosure of ownership change rather than a liquidity event and carries limited immediate market-significance, though it changes beneficial ownership reporting and may affect future voting alignments.

TL;DR: Transfer to family trusts is a governance/ownership reallocation, not an operational or regulatory action.

The report indicates the CEO used trusts to hold shares for family members and expressly disclaims beneficial ownership of those trust holdings. The filing follows Section 16 reporting requirements and was executed via attorney-in-fact. From a governance perspective, the beneficial ownership structure shifts some shares into indirect trust control, which should be tracked for future voting and related-party disclosure but does not by itself indicate a change in management control or corporate policy.

Vivek Jain, presidente e amministratore delegato di ICU Medical, ha presentato un Form 4 che rivela operazioni datate 09/12/2025. La dichiarazione mostra un regalo di 63,641 azioni ordinarie a due trust istituiti per membri della famiglia che condividono lo stesso domicilio; la persona riportante nega la proprietà beneficiaria delle azioni detenute da tali trust. Dopo le operazioni riportate, il signor Jain detiene direttamente 66,508 azioni e i trust detengono indirettamente 152,339 azioni. Il modulo è stato firmato da un procuratore il 09/15/2025.

Vivek Jain, presidente y director ejecutivo de ICU Medical, presentó un Form 4 que revela transacciones fechadas el 09/12/2025. La declaración muestra un regalo de 63,641 acciones comunes a dos fideicomisos establecidos para miembros de la familia que comparten el mismo domicilio; la persona informante niega la titularidad beneficiosa de las acciones que poseen esos fideicomisos. Después de las transacciones reportadas, el Sr. Jain retiene directamente 66,508 acciones y los fideicomisos poseen indirectamente 152,339 acciones. El formulario fue firmado por un apoderado el 09/15/2025.

Vivek Jain, ICU Medical의 회장 겸 CEO가 09/12/2025로 기재된 거래를 밝히는 Form 4를 보고했습니다. 제출 문서는 같은 거주지를 공유하는 가족 구성원을 위해 설립된 두 개의 트러스트에 63,641주 자사주가 증여되었음을 보여주며, 보고자는 해당 트러스트가 보유한 주식에 대한 실질적 소유권을 부인합니다. 보고된 거래 이후 Jain 씨는 직접 66,508주를 보유하고 있으며 트러스트는 간접적으로 152,339주를 보유합니다. 양식은 09/15/2025에 대리인이 서명했습니다.

Vivek Jain, président-directeur général d'ICU Medical, a déclaré un Form 4 révélant des transactions datées du 09/12/2025. Le dépôt montre un don de 63 641 actions ordinaires à deux fiducies établies pour des membres de la famille qui partagent le même domicile; la personne déclarant nie la propriété bénéficiaire des actions détenues par ces fiducies. Après les transactions signalées, M. Jain détenait directement 66 508 actions et les fiducies détenaient indirectement 152 339 actions. Le formulaire a été signé par un mandataire le 09/15/2025.

Vivek Jain, Vorsitzender und CEO von ICU Medical, hat einen Form 4 eingereicht, der Transaktionen datiert auf den 09/12/2025 offenlegt. Die Einreichung zeigt eine Schenkung von 63.641 Stammaktien an zwei Treuhandfonds, die für Familienmitglieder eingerichtet wurden, die im selben Haushalt leben; die meldende Person bestreitet das wirtschaftliche Eigentum an den Aktien, die von diesen Treuhandfonds gehalten werden. Nach den gemeldeten Transaktionen hielt Herr Jain direkt 66.508 Aktien, und die Treuhandfonds hielten indirekt 152.339 Aktien. Das Formular wurde von einem Bevollmächtigten am 09/15/2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Jain Vivek

(Last) (First) (Middle)
951 CALLE AMANECER

(Street)
SAN CLEMENTE CA 92673

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/12/2025 G(1) 63,641 D $0.0 66,508 D
Common Stock 09/12/2025 G 63,641 A $0.0 152,339(1) I by Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction represented a gift of securities from the reporting person to two trusts for the benefit of family members, who share the same household. The reporting person disclaims beneficial ownership of the shares held by the trusts, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
By: Paula Darbyshire, Attorney-in-Fact For: Vivek Jain 09/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Vivek Jain report on Form 4 for ICUI?

The Form 4 reports a gift transfer of 63,641 shares on 09/12/2025 to two family trusts; the reporting person disclaims beneficial ownership of those shares.

How many shares does Vivek Jain still directly own after the transaction?

He retained 66,508 shares of common stock as direct beneficial ownership following the reported transactions.

How many shares are held indirectly by the trusts after the transfer?

The trusts hold 152,339 shares indirectly according to the Form 4 filing.

When was the Form 4 signed and who signed it?

The Form 4 was executed by Paula Darbyshire, Attorney-in-Fact for Vivek Jain on 09/15/2025.

Was this transaction a sale or a gift?

This transaction was a gift of securities to two trusts, not a sale; price is listed as $0.0 in the filing.
Icu Medical

NASDAQ:ICUI

ICUI Rankings

ICUI Latest News

ICUI Latest SEC Filings

ICUI Stock Data

2.88B
23.97M
3.14%
113.48%
5.47%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
SAN CLEMENTE